RETRACTED: Identification of an antitumor immune response of polyhistidine through a toll-like receptor 4-dependent manner.
Department of Gastroenterology, The Tenth People's Hospital of Shanghai, Tongji University, Shanghai 200072, PR China; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: [email protected]
- Published Article
Biochemical and Biophysical Research Communications
- Publication Date
Oct 10, 2014
Polyhistidine is widely used for the delivery of nucleic acids and antibodies into the cell cytoplasm. However, little attention has been concerned on the effect of polyhistidine on the immune system. In this work, we identify a novel function of polyhistidine as an activator of the immune system. Single-molecule fluorescence imaging and single-molecule force measurements show that polyhistidine binds specifically to the toll-like receptor 4 (TLR4), inducing receptor dimerization and activation. Moreover, in a B16 melanoma model we demonstrate that polyhistidine treatment inhibits tumor growth in TLR4(+/+) but not TLR4(-/-) mice. These results suggest the potential use of polyhistidine for cancer immunotherapy.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/07/2017 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/25264106